TW243414B - - Google Patents

Info

Publication number
TW243414B
TW243414B TW081109071A TW81109071A TW243414B TW 243414 B TW243414 B TW 243414B TW 081109071 A TW081109071 A TW 081109071A TW 81109071 A TW81109071 A TW 81109071A TW 243414 B TW243414 B TW 243414B
Authority
TW
Taiwan
Application number
TW081109071A
Other languages
Chinese (zh)
Original Assignee
Ss Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ss Seiyaku Kk filed Critical Ss Seiyaku Kk
Application granted granted Critical
Publication of TW243414B publication Critical patent/TW243414B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW081109071A 1991-11-15 1992-11-13 TW243414B (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30036191 1991-11-15

Publications (1)

Publication Number Publication Date
TW243414B true TW243414B (OSRAM) 1995-03-21

Family

ID=17883858

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081109071A TW243414B (OSRAM) 1991-11-15 1992-11-13

Country Status (5)

Country Link
US (1) US5496819A (OSRAM)
EP (1) EP0612526A4 (OSRAM)
CA (1) CA2121603A1 (OSRAM)
TW (1) TW243414B (OSRAM)
WO (1) WO1993009783A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601839A (en) * 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
CN1194670C (zh) * 1998-02-06 2005-03-30 日本Bcg制造株式会社 用于传染病检测和诊断的方法和组合物
US6211296B1 (en) 1998-11-05 2001-04-03 The B. F. Goodrich Company Hydrogels containing substances
US6455067B1 (en) * 2000-05-24 2002-09-24 Sang-A Pharmaceutical Co., Ltd. Transdermal patch for nonsteroidal antiinflammatory drug(s)
US7955616B2 (en) * 2003-09-23 2011-06-07 Orthocon, Inc. Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
US8105628B2 (en) * 2003-09-23 2012-01-31 Orthocon, Inc. Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
CA2539635A1 (en) 2003-09-23 2005-04-21 Orthotherapeutics, Llc. Bioabsorbable putty-like hemostatic implants
US8603528B2 (en) * 2004-09-16 2013-12-10 Abyrx, Inc. Compositions and method for the reduction of post-operative pain
JP2006188500A (ja) * 2004-12-08 2006-07-20 Toyama Chem Co Ltd ピロキシカムを含有する外用液剤
AU2008293431B2 (en) 2007-08-31 2013-07-04 Cytopherx, Inc. Selective cytopheresis devices and related methods thereof
KR101539801B1 (ko) * 2007-12-12 2015-07-27 데이고꾸세이약꾸가부시끼가이샤 록소프로펜 함유 수성 첩부제
ES2909788T3 (es) 2010-10-15 2022-05-10 Seastar Medical Inc Cartucho de citaféresis y uso del mismo
AU2012364759A1 (en) 2011-10-14 2014-06-05 Cytopherx, Inc. Cartridge and method for increasing myocardial function
KR20210133821A (ko) 2020-04-29 2021-11-08 신신제약 주식회사 피록시캄을 함유하는 경피 흡수 제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0794394B2 (ja) * 1986-12-24 1995-10-11 前田薬品工業株式会社 消炎鎮痛外用貼付剤
ATE80313T1 (de) * 1988-02-29 1992-09-15 Pfizer Mittel zur erhoehung des transdermalen penetrationsflusses.
US4814168A (en) * 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
JP2857882B2 (ja) * 1988-11-02 1999-02-17 富山化学工業株式会社 ピロキシカムのプラスター剤
ATE123237T1 (de) * 1990-08-24 1995-06-15 Spirig Ag Verfahren zur herstellung von pellets.

Also Published As

Publication number Publication date
EP0612526A1 (en) 1994-08-31
WO1993009783A1 (en) 1993-05-27
EP0612526A4 (en) 1995-08-02
US5496819A (en) 1996-03-05
CA2121603A1 (en) 1993-05-16

Similar Documents

Publication Publication Date Title
DE4290947T1 (OSRAM)
DE4292255T1 (OSRAM)
DE4291827T1 (OSRAM)
DK0533071T3 (OSRAM)
DE4292209T1 (OSRAM)
EP0497345A3 (OSRAM)
TW243414B (OSRAM)
IN180837B (OSRAM)
DE4290298T1 (OSRAM)
DE4291983T1 (OSRAM)
DK0511526T3 (OSRAM)
DK0525857T3 (OSRAM)
DE4292012T1 (OSRAM)
ECSM91549U (OSRAM)
ATA245291A (OSRAM)
ECSDI910044S (OSRAM)
ECSM91574U (OSRAM)
DE4291112T1 (OSRAM)
ECSM91540U (OSRAM)
ECSM91548U (OSRAM)
ECSM91552U (OSRAM)
ECSM91561U (OSRAM)
ECSM91576U (OSRAM)
JPH0498486U (OSRAM)
AU7633391A (OSRAM)